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ABSTRACT
Purpose: To determine the prevalence of trachoma in four Local Government Areas (LGAs) of Kogi
State, Nigeria.
Methods: In June 2014, we conducted population-based, cross-sectional surveys according to
Global Trachoma Mapping Project (GTMP) protocols in selected LGAs of Kogi State. In each LGA,
25 clusters were selected with probability proportional to size. In each of these clusters, 25
households were enrolled for the survey. All residents of selected households aged ≥1 year
were examined by GTMP-certified graders for trachomatous inflammation–follicular (TF) and
trichiasis using the simplified trachoma grading scheme. Data on sources of household water
and types of sanitation facilities were collected through questioning and direct observation.
Results: The age-adjusted TF prevalence in 1–9-year-olds ranged from 0.4% (95% CI 0.1–0.8%) in
Bassa to 1.0% (95% CI 0.3–1.9%) in Omala. Across all four LGAs, only one case of trichiasis was
found; this individual was in Omala, giving that LGA a trichiasis prevalence in individuals aged
≥15 years of 0.02% (95% CI 0.00–0.07%). Between 77 and 88% of households had access to water
for hygiene purposes, while only 10–30% had access to improved sanitation facilities.
Conclusion: Trachoma is not a public health problem in any of the 4 LGAs surveyed. There is,
however, the need to increase access to adequate water and sanitation services to contribute to
the health and social and economic well-being of these communities.
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Introduction
Trachoma is an infectious disease of the eye caused by
particular strains1,2 of the bacterium Chlamydia tracho-
matis. It is spread by direct contact with the ocular or nasal
discharges of an infected person, by contact with shared
clothing and towels carrying those discharges, or via eye-
seeking flies (Musca sorbens3) which act as mechanical
vectors. Blindness from trachoma occurs after repeated
cycles of infection and resolution over years to decades,4,5
approaching slowly and painfully.6 It is the leading infec-
tious cause of blindness worldwide.7
Since 1993,8 the World Health Organization has
recommended implementation of the SAFE (surgery,
antibiotics, facial cleanliness, environmental
improvement) strategy in populations where trachoma
presents a threat to public health. In order to justify use
of the SAFE strategy despite competing public health
priorities and limited resources, district-level data on
the prevalence of trachoma are needed.9 To this end,
from 2012 to 2016, the Global Trachoma Mapping
Project (GTMP)10 supported countries11 to undertake
population-based prevalence surveys in areas in which
trachoma was suspected to be endemic.
Nigeria has a high trachoma burden.12–26 Kogi State,
located in central Nigeria, has a population of 3.3 million
people27 and had not previously been formally surveyed
for the disease. To its north, Kogi borders currently or
previously trachoma-endemic districts (Local Government
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Areas, LGAs) of Nasarawa16 andNiger24 States. The aim of
this series of surveys was to determine the LGA-level
prevalence of key signs of trachoma in selected northern
LGAs of Kogi State bordering trachoma-endemic (or pre-
viously endemic) LGAs, and to generate data on house-
hold-level access to water and sanitation.28 These data are
needed to guide trachoma elimination efforts at national-,
state- and LGA-levels, as required.
Methods
We undertook a population-based prevalence survey in
each of four LGAs in Kogi State, as part of the GTMP.
Sample size
For each LGA, we calculated that selecting 25 house-
holds in each of 25 clusters would allow 1019 children
aged 1–9 years to be examined. This sample size would
be sufficient to allow an expected 10% prevalence of
trachomatous inflammation–follicular (TF) to be esti-
mated with absolute precision of 3%, assuming a design
effect of 2.65 and inflating by a factor of 1.2 to adjust
for non-response.20–26,29
Team training
Each field team included a trachoma grader and a data
recorder, who were recruited by the local Ministry of
Health, were trained and certified according to GTMP
protocols, as described in detail elsewhere.29 Grader
trainees were required to pass slide- and field-based
tests of diagnostic accuracy and recorder trainees were
required to pass an electronic examination on the accu-
racy of their data capture.
Household selection
In each surveyed LGA, we initially selected 25 villages
using a systematic, probability-proportional-to-village-
size methodology.30 In selected villages, we chose 25
households using the random walk method, as prac-
ticed in other Nigerian States that undertook trachoma
mapping with GTMP support.20–25
Data collection
At each selected household, global positioning system
coordinates were recorded. Data on water and sanita-
tion access were collected through interviews with
household members and assessment of household sani-
tation facilities, where such facilities were present. All
household residents aged ≥1 year were eligible to be
included in the survey. Consenting individuals were
examined by the grader for TF, trachomatous inflam-
mation–intense (TI), and trichiasis, using the criteria
set out in the WHO simplified grading scheme,31 a 2.5×
magnifying loupe and sunlight illumination. All data
were recorded using LINKS software29,32 running on
Android smartphones, and uploaded to a secure Cloud-
based server once the phones were within range of a
suitable network.29
Ethical considerations
We adhered to the tenets of the Declaration of
Helsinki.33 Adults gave informed verbal consent for
their own participation. Verbal consent for participa-
tion of those aged <15 years was provided by a parent
or guardian. All consent was documented electronically
by the recorder. Individuals with active trachoma were
given two tubes of 1% tetracycline eye ointment and
they (or a care-giver) were instructed on its application.
Individuals with trichiasis were referred for surgery by
a certified provider. The protocol was approved by the
ethics committee of the London School of Hygiene &
Tropical Medicine (reference 6319) and the National
Health Research Ethics Committee of Nigeria
(NHREC/01/01/2007).
Data analysis
Cluster-level proportions of children with TF were
adjusted for age in 1-year age bands, and cluster-level
proportions of ≥15-year-olds with trichiasis were
adjusted for gender and age in 5-year age bands,
using data from the 2006 census.27 Confidence intervals
(CIs) were calculated from adjusted cluster-level pro-
portions by bootstrapping, with replacement, over
10,000 replications.
Univariable and multivariable analyses for associa-
tions of TF in 1–9-year-olds were performed using R
3.3.3 (2017; R Foundation for Statistical Computing,
Vienna, Austria). For these analyses, we pooled data
across all four LGAs, and used a multi-level hierarchical
model to account for clustering at village- and LGA-level.
Prior to conducting multivariable analyses, we used
Mantel–Haenszel tests of association to examine colli-
nearity between explanatory variables, but this was not
an absolute exclusion criterion. Age and sex were
included in the multivariable model a priori, and a
stepwise inclusion approach was used, adding variables
that were statistically significant in the univariable ana-
lyses (Wald test), and retaining them in the final model
if they were found to be statistically significant (LRT).
34 J. J. ALADA ET AL.
Results
Fieldwork was undertaken in June 2014. For three of
the four LGAs, fewer than 750 1–9-year-old children
were examined during field team visits to 25 house-
holds in 25 villages, and so additional villages were
selected, as shown in Table 1. In total, after recruitment
of additional clusters, 3081 households were surveyed
in 124 villages. There were 12,021 individuals resident
in those households, of whom 6602 (55%) were female.
Graders examined 11,404 (95%) residents; 326 (3%)
were absent, and consent for examination was not
given for 239 (2%, Table 1). Of individuals examined,
6336 (56%) were female. A total of 3884 children aged
1–9 years (1974 boys) were examined. In Omala, one
58-year-old woman had bilateral trichiasis, giving an
age- and gender-adjusted prevalence of trichiasis in
individuals aged ≥15 years for that LGA of 0.02%
(95% CI 0.00–0.07%). No cases of trichiasis were seen
in Bassa, Yagba East or Yagba West (Table 2). The age-
adjusted TF prevalence in 1–9-year-olds ranged from
0.4% (95% CI 0.1–0.8%) in Bassa to 1.0% (95% CI 0.3–
1.9%) in Omala (Table 2, Figure 1).
The proportion of households with access to an
improved source of water for face-washing ranged
from 30% in Bassa to 94% in Yagba West. Only 10%
of households in Bassa LGA had an improved latrine
compared to 33% in Yagba West. In all four LGAs, a
majority of households had a source of water for face-
washing within a 30 minute round trip (Table 3).
Associations of TF
We categorized age in 3-year intervals, and this group-
ing was shown to fit our final model better than using
1-year intervals (LRT, p = 0.0008) or 4-year intervals
(LRT, p = 0.001).
There was a clear difference in the prevalence of TF
among children by age group, with higher disease pre-
valence in children between the ages of 4–6 years
(Figure 2).
Results of the univariable analysis for associations of
TF in children aged 1–9 years are shown in Table 4.
Children living in households reporting open defaeca-
tion did not have significantly different odds of TF to
those with access to a latrine facility. As a sensitivity
analysis, we also compared the odds of TF for children
living in households with access to improved sanitation
versus those in households with unimproved sanitation
(access to an unimproved latrine or use of open defae-
cation); the difference was not significant (p = 0.3).
There was a similar lack of association of TF with
access to private versus public or shared latrine. Ta
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Table 2. Prevalence of trachomatous inflammation–follicular (TF) in 1–9-year-olds and prevalence of trichiasis in ≥15-
year-olds, by Local Government Area, Global Trachoma Mapping Project, Kogi State, Nigeria, June 2014.
Local
Government
Area
Number of 1–9-
year-olds with TF
Age-adjusted TF prevalence in
1–9-year-olds (%) [95% CI]
Number of ≥15-year-
olds with trichiasis
Age- and gender-adjusted trichiasis
prevalence in ≥15-year-olds (%) [95% CI]
Bassa 13 0.4 (0.1–0.8) 0 0.00
Omala 22 1.0 (0.3–1.9) 1 0.02 (0.00–0.07)
Yagba East 25 0.9 (0.0–2.6) 0 0.00
Yagba West 23 0.4 (0.0–1.0) 0 0.00
Figure 1. Prevalence of trachomatous inflammation-follicular (TF) in 1–9-year-old children, Global Trachoma Mapping Project, Kogi
State, Nigeria, June 2014.
Table 3. Household-level access to water and sanitation, by Local Government Area (LGA), Global Trachoma Mapping Project,
Kogi State, Nigeria, June 2014.
LGA
Number of households
surveyed Improved washing water source, n (%) Washing water source <1km, n (%) Improved sanitation facility, n (%)
Bassa 663 202 (30) 502 (76) 66 (10)
Omala 614 338 (55) 471 (77) 164 (27)
Yagba East 936 762 (81) 787 (84) 230 (25)
Yagba West 868 817 (94) 761 (88) 285 (33)
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Figure 2. Prevalence of trachomatous inflammation–follicular (TF) among 1–9-year-olds, by age, Global Trachoma Mapping Project,
Kogi State, Nigeria, June 2014.
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Results of the multivariable analysis are shown in
Table 5. Compared to children aged 7–9 years, children
aged 4–6 years had 2.6 (95% CI 1.1–6.3) times greater
odds of having TF. Children living in households with
four or more children had 2.4 (95% CI 1.1–5.3) times
greater odds of having TF than children in households
with fewer than four children.
Discussion
Trachoma is not a public health problem in these Kogi
State LGAs. The TF prevalence in 1–9-year-olds was
well below 5% in each LGA surveyed, and the preva-
lence of trichiasis in individuals aged ≥15 years was
<0.2% in each LGA, indicating that none of the com-
ponents of the SAFE strategy need be deployed at
public health level for the purposes of trachoma
elimination.34 Data from Nigeria’s 2007 National
Blindness and Visual Impairment Survey35 indicate
that risk of trichiasis and corneal opacity is concen-
trated towards the country’s north,18 and we take the
present set of results as confirmation that trachoma
mapping south of the LGAs surveyed here is not indi-
cated. Trachoma elimination efforts should be directed
to the north of Nigeria, where trachoma has been
shown to be of public health importance.18–25
Although a majority of households in each of these
LGAs had access to a source of water for face-washing
within a 30 minute round trip of the household, less than
one-third of households in each LGA had access to an
improved sanitation facility. It could therefore be hypothe-
sized that despite low sanitation coverage, relatively good
access to water may have facilitated maintenance of clean
faces, contributing to low levels of active disease.36,37
However, in our analyses, neither access to water nor
access to latrines was significantly associated with the
presence of TF in children in these LGAs. Characteristics
independently associated with TF were being aged
4–6 years, and living in a household with four or more
children. Children aged 4–6 years may be less likely to
practice facial hygiene than children aged 7–9 years.
Children in households with more children may have
more frequent or more sustained contact with other chil-
dren than those living in households with fewer children.
However, the importance of the associations that we
observed here may be questionable, given the very low
prevalence of active trachoma in this population.38
Our work had some limitations. First, the random
walk was used in GTMP sub-projects in northern
Nigeria because of local insecurity and our consequent
Table 4. Univariable analysis of associations of trachomatous inflammation–follicular in 1–9-year-olds, Global Trachoma Mapping
Project, Kogi State, Nigeria, June 2014.
Variable Univariable ORa (95% CI)b P-valuec
Age, years 1–3 0.49 (0.12–1.99) 0.3
4–6 2.57 (1.06–6.21) 0.04
7–9 1 –
Children aged 1–9 years in household, n 1–3 1 –
≥4 2.35 (1.06–5.17) 0.03
Gender Male 1 –
Female 1.06 (0.51–2.18) 0.9
Open defecation (no facilities, bush, or field) Yes 4.53 (0.46–44.71) 0.2
No 1 –
Surface water used as drinking source Yes 3.43 (0.83–14.22) 0.09
No 1 –
Surface water used for face-washing Yes 3.14 (0.83–11.82) 0.09
No 1 –
Time to main source of drinking water, minutes <30 1 –
≥30 2.41 (0.67–8.67) 0.2
Time to main source of water used for face-washing, minutes <30 1 –
≥30 1.93 (0.51–7.28) 0.3
Altitude, metres above sea level <250 1 –
≥250 1.46 (0.51–4.20) 0.5
aUnivariable random effects regression accounting for clustering at village- and LGA-level.
bWald’s 95% confidence interval.
cWald’s test.
OR, odds ratio; CI, confidence interval.
Table 5. Multivariable analysis of risk factors related to tracho-
matous inflammation–follicular in 1–9-year-olds, Global
Trachoma Mapping Project, Kogi State, Nigeria, June 2014.
Variable
Multivariable ORa
(95% CI)b
P-
valuec
Age, years 0.004
1–3 0.49 (0.12–1.98) –
4–6 2.59 (1.07–6.26) –
7–9 1 –
Children aged 1–9 years in
household, n
0.03
1–3 1 –
≥4 2.39 (1.08–5.30) –
aMultivariable random effects regression accounting for clustering at vil-
lage- and LGA-level. Multivariable ORs are adjusted for sex, age and
number of children aged 1–9 years in household.
bWald’s 95% confidence interval.
cLikelihood ratio test of inclusion/exclusion of variable in final model.
OR, odds ratio; CI, confidence interval.
OPHTHALMIC EPIDEMIOLOGY 37
desire to use a household-sampling strategy that was
familiar to local residents.20–25 We used it in Kogi State
by extension, even though we know it to be epidemio-
logically sub-optimal.39–41 Second, in three of the four
LGAs, we added extra clusters mid-survey, due to
lighter-than-expected recruitment of examinees in the
first 25 selected villages. We recognize that adding
clusters to a set of previously-chosen, systematically
sampled clusters compromises the principle of equal-
probability sampling. It is somewhat reassuring to note
that prevalence estimates were below WHO-defined
thresholds34 for elimination as a public health problem
whether generated with or without the additional clus-
ters. Third, our surveys were under-powered for pre-
cisely estimating the LGA-level prevalence of trichiasis,
but the fact that only one individual with trichiasis was
found amongst 6381 adults examined across four LGAs
reinforces the impression that end-stage trachoma is
rare here. Fourth, we did not examine eyes with tri-
chiasis for conjunctival scar. Recognition of the impor-
tance of doing so arose in late 2015,42 after these
surveys were complete, but again, only one trichiasis
case was seen, so the lack of conjunctival scarring data
is perhaps inconsequential when assessing the public
health relevance of the Kogi findings.
All four LGAs meet the elimination target for TF
(prevalence <5% in 1–9-year-olds) and trichiasis (preva-
lence <0.2% in ≥15-year-olds). However, in order to
achieve the United Nations Sustainable Development
Goals for water and sanitation, safeguard health, improve
quality of life, and fulfil the human right to water and
sanitation, there is a need to improve access to adequate
water and sanitation services in these LGAs.
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